Bowles, Kathryn R. https://orcid.org/0000-0003-3311-5245
Pugh, Derian A.
Liu, Yiyuan
Patel, Tulsi
Renton, Alan E.
Bandres-Ciga, Sara
Gan-Or, Ziv
Heutink, Peter
Siitonen, Ari
Bertelsen, Sarah
Cherry, Jonathan D.
Karch, Celeste M.
Frucht, Steven J.
Kopell, Brian H.
Peter, Inga
Park, Y. J.
,
Charney, Alexander
Raj, Towfique
Crary, John F.
Goate, A. M.
Funding for this research was provided by:
BrightFocus Foundation
Association for Frontotemporal Degeneration
CurePSP
Rainwater Charitable Foundation
National Institutes of Health
Michael J. Fox Foundation for Parkinson's Research
Canadian Consortium on Neurodegeneration in Aging
Canada First Research Excellence Fund
Fonds de Recherche du Québec - Santé
Article History
Received: 23 September 2021
Accepted: 21 June 2022
First Online: 15 July 2022
Declarations
:
: <b>Ethical Approval and Consent to Participate</b>Not applicable.
: All authors read and approved the final manuscript
: AMG: Scientific advisory board (SAB) for Denali Therapeutics (2015–2018), SAB for Pfizer (2019), SAB for Genentech, consultant for GSK, AbbVie, Biogen and Eisai. All other authors declare no competing interests.